Norris Medicines Ltd Price Performance
- Day's Low
- ₹0
- Day's High
- ₹0
₹ 0
- 52-w low
- ₹0
- 52-w high
- ₹0
0
- Day's open
₹0 - Previous close
₹0 - VWAP
₹0 - Lower price band
₹0 - Upper price band
₹0
Today's Market Action
Its last traded stock price on BSE was 17.76 down by -4.98%. The total volume of shares on NSE and BSE combined was 1,018 shares. Its total combined turnover was Rs 0.00 crores.
Norris Medicines Ltd Medium and Long Term Market Action
The stock price of Norris Medicines Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.
Norris Medicines Ltd Fundamentals
-
Market Cap (Cr): 18.7
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Norris Medicines Ltd Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About Norris Medicines Ltd
Data not available.
Norris Medicines Ltd FAQ's
What is Share Price of Norris Medicines Ltd?
What is the Market Cap of Norris Medicines Ltd?
What is PE Ratio of Norris Medicines Ltd?
What is PB Ratio of Norris Medicines Ltd?
What is the CAGR of Norris Medicines Ltd?
How to Buy Norris Medicines Ltd Share?
Financials
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
News
Review
Pros
Above Average Growth Rate
Cons
Low Sustainable RoE
Low Return on Capital Employed
Poor Cash Flow Conversion
Negative operating earnings and interest coverage
Low Pricing Power & High Competition
Capital Intensive Business
Negative Equity
Poor Working Capital Cycle
Poor Corporate Governance
Negative Margin of Safety
Valuation Analysis
Margin of safety
(25/03/2025)
(25/03/2025)


37
0% People are bullish about Norris Medicines Ltd
0 % People are bearish about Norris Medicines Ltd